GUCUK, E. Et Al. 2014. Spironolactone does not alter cystatin C levels in mildly symptomatic systolic heart failure patients. EUROPEAN JOURNAL OF HEART FAILURE , vol.16 , 69.

GUCUK, E., Suljevic, S. A., KARALOK, N., GURAY, Y., & Demirel, H., (2014). Spironolactone does not alter cystatin C levels in mildly symptomatic systolic heart failure patients. EUROPEAN JOURNAL OF HEART FAILURE , vol.16, 69.

GUCUK, ŞENAY Et Al. "Spironolactone does not alter cystatin C levels in mildly symptomatic systolic heart failure patients," EUROPEAN JOURNAL OF HEART FAILURE , vol.16, 69, 2014

GUCUK, ŞENAY Et Al. "Spironolactone does not alter cystatin C levels in mildly symptomatic systolic heart failure patients." EUROPEAN JOURNAL OF HEART FAILURE , vol.16, pp.69, 2014

GUCUK, E. Et Al. (2014) . "Spironolactone does not alter cystatin C levels in mildly symptomatic systolic heart failure patients." EUROPEAN JOURNAL OF HEART FAILURE , vol.16, p.69.

@article{article, author={ŞENAY AKIN Et Al. }, title={Spironolactone does not alter cystatin C levels in mildly symptomatic systolic heart failure patients}, journal={EUROPEAN JOURNAL OF HEART FAILURE}, year=2014, pages={69} }